I wouldn't want to let Stevan look like he stands alone here. I am terrified by such statements as those made here by Mr. Belenkiy (whom, by the way, I do not know).
These statements are not only peremptory, but they take us back 15 years in the dark ages of the nascent OA era. I admire Stevan for responding to such uninformed arrogance. It is a pity that this person has not even tried to get some reliable information prior to swarm into this forum, wasting everybody's time. Bernard Rentier Chair, EOS http://www.openscholarship.org Le 31 juil. 2012 à 11:43, Stevan Harnad <har...@ecs.soton.ac.uk> a écrit : > > On 2012-07-30, Ari Belenkiy wrote in LIBLICENSE: > >> Stevan Harnad, >> >> I failed to hear this time the key word "taxpayer" that permeated your >> earlier writings. > > Here's the word: > > Research is funded by the *tax-payer* so that it can be used, applied and > built upon, toward progress in further research and applications, to the > benefit of the *tax-payer*. > > Access-denial denies *tax-payers* the full usage, progress, applications and > benefits from the research they funded. > > Research usage, applications, progress and benefits do not come from > restricting access to users in the country in which the research was > funded and conducted. (Not even subscription-access does that!) > > Research is global, and the intended users of research are worldwide. > >> Thus, the taxpayer's status is unimportant? You argued for the >> well-being of an "ideal" taxpayer - is this a researcher? > > Not at all, as you see. > >> I cannot see how the modern system prevents a serious researcher from >> an immediate intake in other's research. I did not hear of any >> independent researcher in Medicine who works inside of any institution >> which cannot allow itself to buy all necessary journals. > > Look again. > >> And the third response on the list convinced me again that it is >> Medicine that matters most for the OA advocates. > > I cannot follow. OA is for all research, in all disciplines. What research > fails to benefit from being accessible to all its intended users, rather > than just those that can afford to subscribe? > > (Research is not being funded and conducted by the tax-payer in order > to generate access-toll revenue for the publisher, let alone the researcher. > Refereed research journal publication is not trade publication. It is > written > for research uptake and impact, not for royalty income.) > >> Perhaps this is lobbying for the people with serious medical problems. >> Though then your position is quite understandable, you still a >> lobbyist, like any other group with particular interests. > > I (and most other OA advocates) are "lobbying" for research progress, > in all disciplines, worldwide. > > Stevan Harnad > > >> >> On Thu, Jul 26, 2012 at 2:29 PM, LIBLICENSE <liblice...@gmail.com> wrote: >> >>> From: Stevan Harnad <har...@ecs.soton.ac.uk> >>> Date: Thu, 26 Jul 2012 06:35:40 -0400 >>> >>>> From: Ari Belenkiy <ari.belen...@gmail.com> >>>> Date: Tue, 24 Jul 2012 18:50:34 -0700 >>>> >>>> Despite his valuable personal recollections, Steven Harnad so far >>>> failed to answer two my questions: >>>> >>>> 1. Why the EU research must be immediately open for the non-EU >>>> researchers (who are not, in particularly, EU-taxpayers)? >>> >>> Because research is done and reported in order to be used, applied >>> and built upon by other researchers -- not just those who can >>> subscribe to the journal in which it appeared, or who live in the same >>> country as the researcher. >>> >>>> 2. Why the EU taxpayers, who contribute different amounts in tax, must >>>> have equal opportunities to access the results of the EU research? >>> >>> The primary purpose of providing OA is so that the primary intended >>> users of the research (researchers worldwide) can use, apply and >>> build upon it. Access by the interested public is a secondary bonus. >>> >>>> [Of course, EU could be substituted here for Britain or the US or >>>> Russia or China or etc.] >>> >>> If you want your research findings to be confidential and >>> restricted, you don't publish them at all. >>> >>> OA is for research published in peer-reviewed journals, for all >>> potential users. The journal price-tag is an access-restrictor. >>> >>> Stevan Harnad > > > _______________________________________________ > GOAL mailing list > GOAL@eprints.org > http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal _______________________________________________ GOAL mailing list GOAL@eprints.org http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
